HomeCancer

Cancer

Bridging the hole: Mitigating disparities in prostate most cancers outcomes

Early most cancers detection requires efficient, accessible, and actionable screening approaches. The prostate-specific antigen (PSA) check is the present customary for prostate most...

Metastatic Prostate Most cancers Scientific Trial Pipeline Insights That includes 75+ Corporations

The metastatic prostate most cancers market is pushed by developments in focused therapies and immunotherapies, catering to a rising ageing inhabitants. Early detection...

Sidney Farber Scholar Pursues Progressive Remedies for Leukemia | Dana-Farber Most cancers Institute

Printed: July 9, 2024Written by: Beth DoughertyDoctor-scientist Franziska Wachter, MD, got here to Dana-Farber 10 years in the past as a postdoctoral fellow...

Hot Topics